Clinical Trials Browser

Terminated × Turcot syndrome × tislelizumab × Clear all

NCT04906382 2025-02-13

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Phase EARLY_PHASE1 Terminated

GastrointestinalGynecologic

Turcot syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms